ReviewReumatologia2020
Uveitis associated juvenile idiopathic arthritis - presentation of recently published international recommendations for diagnostic and therapeutic procedures.
Review in Reumatologia, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 3 citations in OpenAlex.
- Serological biomarkers of JIA-associated uveitis: ANA titers, ANA AC-30 staining pattern and prefoldin 5 antibodies.Arthritis research & therapy · 2026Article
- Ocular involvement and visual prognosis in juvenile idiopathic arthritis associated uveitis.International journal of ophthalmology · 2025Article
- A clearer vision: insights into juvenile idiopathic arthritis-associated uveitis.Proceedings (Baylor University. Medical Center) · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Uveitis is one of the most common extra-articular manifestations in juvenile idiopathic arthritis (JIA) and occurs in 20-30% of children with this disease. Uveitis occurs at various frequencies and varies in character in individual clinical subtypes of the disease. Normally it is asymptomatic or mildly symptomatic; thus, in 85% of the patients the first symptoms of uveitis and its subsequent episodes pass unobserved. In 75% of cases inflammation affects both eyes. Most often it occurs in the oligoarticular subtypes of JIA, especially in patients aged 2-4 years, who are diagnosed with anti-nuclear antibodies in serum. Uncontrolled uveitis may lead to severe complications that may result in vision loss. To date, there are no generally accepted diagnostic and therapeutic standards for this disease. This article presents the latest recommendations by ophthalmologists and rheumatologists for the detection, treatment, and monitoring of children with JIA-associated uveitis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.